<> Indoco Remedies Share Price Today: Live Indoco Remedies Share Price NSE/BSE | 5paisa
INDOCO

Indoco Remedies Share PriceIndoco Remedies

₹333.4
-4.15 (-1.23%)
As on 05 February, 2023 | 19:53 BSE: 532612 NSE: INDOCO

Indoco Remedies Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Indoco Remedies

Start SIP

Indoco Remedies Share Price

  • Over 1 Month -18.81%
  • Over 3 Month -7.35%
  • Over 6 Month -16.88%
  • Over 1 Year -14.91%

Indoco Remedies Key Statistics

P/E Ratio 19.6
PEG Ratio 1.6
Market Cap Cr 3,072
Price to Book Ratio 3.4
EPS 16.8
Dividend 0.7
Relative Strength Index 33.3
Money Flow Index 27.04
MACD Signal -10.37
Average True Range 17.2

Indoco Remedies Investment Rating

  • Master Rating:
  • Indoco Remedies has an operating revenue of Rs. 1,649.59 Cr. on a trailing 12-month basis. An annual revenue growth of 24% is outstanding, Pre-tax margin of 15% is great, ROE of 17% is exceptional. The company has a reasonable debt to equity of 11%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 91 which is a GREAT score indicating consistency in earnings, a RS Rating of 34 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 107 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Indoco Remedies Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 399405395400
Operating Expenses Qtr Cr 337345337328
Operating Profit Qtr Cr 62887180
Depreciation Qtr Cr 17162018
Interest Qtr Cr 7543
Tax Qtr Cr 10181019
Net Profit Qtr Cr 28503840

Indoco Remedies Technicals

EMA & SMA

Current Price
₹333.4
-4.15 (-1.23%)
  • Bullish Moving Average
  • ___
  • 1
  • Bearish Moving Average
  • ___
  • 15
  • 20 Day
  • 364.3
  • 50 Day
  • 375.37
  • 100 Day
  • 374.36
  • 200 Day
  • 374.8
  • 20 Day
  • 374.44
  • 50 Day
  • 386.63
  • 100 Day
  • 367.86
  • 200 Day
  • 368.48

Indoco Remedies Resistance and Support

PIVOT
₹335.29
Resistance
First Resistance 352.12
Second Resistance 366.69
Third Resistance 383.52
RSI 33.3
MFI 27.04
MACD Single Line -10.37
MACD -16.46
Support
First Resistance 320.72
Second Resistance 303.89
Third Resistance 289.32

Indoco Remedies Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 239,912 6,189,730 25.8
Week 182,355 5,324,778 29.2
1 Month 166,795 5,160,631 30.94
6 Month 120,682 5,078,281 42.08

Indoco Remedies Result Highlights

Indoco Remedies Synopsis

NSE-Medical-Diversified

Indoco Remedies is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1539.72 Cr. and Equity Capital is Rs. 18.43 Cr. for the Year ended 31/03/2022. Indoco Remedies Ltd. is a Public Limited Listed company incorporated on 23/08/1947 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L85190MH1947PLC005913 and registration number is 005913.
Market Cap 3,093
Sales 1,648
Shares in Float 3.78
No of funds 60
Yield 0.45
Book Value 3.42
U/D Vol ratio 0.9
LTDebt / Equity 11
Alpha -0.03
Beta 0.64

Indoco Remedies

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 58.69%58.69%58.69%
Mutual Funds 17.28%17.27%17.39%
Insurance Companies 0.06%0.06%0.13%
Foreign Portfolio Investors 1.23%1.19%1.17%
Individual Investors 16.73%16.85%17.22%
Others 6.01%5.94%5.4%

Indoco Remedies Management

Name Designation
Mr. Suresh G Kare Chairman
Ms. Aditi Panandikar Managing Director
Mr. Sundeep V Bambolkar Joint Managing Director
Dr. Anand Nadkarni Non Executive Director
Mr. D M Gavaskar Independent Director
Mr. Rajiv P Kakodkar Independent Director
Dr.(Ms.) Vasudha V Kamat Independent Director
Mr. Abhijit Y Gore Independent Director

Indoco Remedies Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Indoco Remedies Corporate Action

Date Purpose Remarks
2023-01-24 Quarterly Results
2022-11-10 Quarterly Results
2022-08-09 Quarterly Results
2022-05-17 Audited Results & Final Dividend
2022-02-01 Quarterly Results

Indoco Remedies MF Shareholding

Name Amount(cr)
Nippon India Small Cap Fund - Growth 23701
Franklin India Smaller Companies Fund Growth 7288
HDFC Capital Builder Value Fund Growth 5497
ICICI Prudential Smallcap Fund Growth 4599
Nippon India Pharma Fund - Growth 4563

Indoco Remedies FAQs

What is Share Price of Indoco Remedies ?

Indoco Remedies share price is ₹333 As on 05 February, 2023 | 19:39

What is the Market Cap of Indoco Remedies ?

The Market Cap of Indoco Remedies is ₹3072.3 Cr As on 05 February, 2023 | 19:39

What is the P/E ratio of Indoco Remedies ?

The P/E ratio of Indoco Remedies is 19.6 As on 05 February, 2023 | 19:39

What is the PB ratio of Indoco Remedies ?

The PB ratio of Indoco Remedies is 3.4 As on 05 February, 2023 | 19:39

Q2FY23